Evidence map›Paper›PMID 29889330›Full record

ArticleThe European journal of neuroscience2019

The initiation of cannabis use in adolescence is predicted by sex-specific psychosocial and neurobiological features.

Philip A Spechler, Nicholas Allgaier, Bader Chaarani, Robert Whelan, Richard Watts, Catherine Orr, Matthew D Albaugh, Nicholas D'Alberto, Stephen T Higgins, Kelsey E Hudson and 27 more

Abstract readMulticenter Study
In one paragraph

Article in The European journal of neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Independent brain cortical signatures of risk for adolescent cannabis use and consequences of such use are moderated by sex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Factors associated with cannabis use in early adolescence.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2023
    Article
  11. Article
  12. The ABCD stop signal data: Response to Bissett et al.Developmental cognitive neuroscience · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Philip A SpechlerVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.ORCID 0000-0003-3833-7672
Nicholas AllgaierDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Bader ChaaraniVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.
Robert WhelanSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Richard WattsDepartment of Radiology, University of Vermont, Burlington, VT, USA.
Catherine OrrDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Matthew D AlbaughDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Nicholas D'AlbertoDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Stephen T HigginsVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.
Kelsey E HudsonDepartment of Psychological Science, University of Vermont, Burlington, VT, 05401, USA.
Scott MackeyDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Alexandra PotterDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.
Tobias BanaschewskiMedical Faculty Mannheim, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.
Arun L W BokdeDiscipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College Dublin, Dublin, Ireland.
Uli BrombergUniversity Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Christian BüchelUniversity Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Anna CattrellCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Patricia J ConrodDepartment of Psychiatry, Universite de Montreal, CHU Ste Justine Hospital, Montreal, Canada.
Sylvane DesrivièresCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Herta FlorMedical Faculty Mannheim, Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.
Vincent FrouinNeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.
Jürgen GallinatDepartment of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Penny GowlandSir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.
Andreas HeinzDepartment of Psychiatry and Psychotherapy, Charité, Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.
Bernd IttermannPhysikalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany.
Jean-Luc MartinotDIGITEO Labs, Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud - University Paris Saclay, Gif sur Yvette, France.
Marie-Laure Paillère MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud - Paris Saclay, University Paris Descartes, Paris, France.
Frauke NeesMedical Faculty Mannheim, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.
Dimitri Papadopoulos OrfanosNeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.
Tomáš PausBaycrest and Departments of Psychology and Psychiatry, Rotman Research Institute, University of Toronto, Toronto, ON, M6A 2E1, Canada.
Luise PoustkaDepartment of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, 37075, Göttingen, Germany.
Michael N SmolkaDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
Henrik WalterDepartment of Psychiatry and Psychotherapy, Charité, Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.
Gunter SchumannCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Robert R AlthoffDepartment of Psychological Science, University of Vermont, Burlington, VT, 05401, USA.
Hugh GaravanVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.
IMAGEN Consortium

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI KLEMPERER, ELIAS M · 2013 to 2022
$21.3M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Child Behavior Checklist-Dysregulation Profile: Genes, Environment, & Life CourseK08MH082116 · NIMH · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI ALTHOFF, ROBERT RUSSELL · 2009 to 2013
$950k
Influence of P-glycoprotein in treating brain tumorsR01CA093558 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI MILLER, DONALD W · 2004 to 2006
$568k
Bundesministerium fur Bildung und Forschung 01EV0711Bundesministerium fur Bildung und Forschung 01GS08152CENIR (Centre de NeuroImagerie de Recherche, Pr. S. Lehe ricy) within the ICM institute and the National Institute of Mental Health MH082116cross-NIH alliance that funds Big Data to Knowledge Centers of ExcellenceDeutsche Forschungsgemeinschaft (DFG)European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) LSHM-CT- 2007-037286French MILDT (Mission Interministe rielle de Lutte contre la Drogue et la Toxicomanie)German Federal Ministry of Education and ResearchIMAging GEnetics for MENtal Disorders 602450Innovative Medicine Initiative Project EU-AIMS 115300-2King's College LondonMATRICS 603016Maudsley NHS Foundation TrustMedical Research Council G0901858Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" 93558National Institute for Health Research (NIHR) Biomedical Research Centre at SouthLondonNational Institutes of Health Center of Biomedical Research Excellence P20GM103644NIBIB NIH HHS U54 EB020403NIGMS NIH HHS P20 GM103644NIH HHS U54 EB020403NIMH NIH HHS K08 MH082116Reinhart-Koselleck FOR 1617Reinhart-Koselleck SFB 940/1Reinhart-Koselleck SM 80/7-1Reinhart-Koselleck SP 383/5-1Swedish funding agency FORMASWellcome Trust
6 · The paper itself

Abstract

Cannabis use initiated during adolescence might precipitate negative consequences in adulthood. Thus, predicting adolescent cannabis use prior to any exposure will inform the aetiology of substance abuse by disentangling predictors from consequences of use. In this prediction study, data were drawn from the IMAGEN sample, a longitudinal study of adolescence. All selected participants (n = 1,581) were cannabis-naïve at age 14. Those reporting any cannabis use (out of six ordinal use levels) by age 16 were included in the outcome group (N = 365, males n = 207). Cannabis-naïve participants at age 14 and 16 were included in the comparison group (N = 1,216, males n = 538). Psychosocial, brain and genetic features were measured at age 14 prior to any exposure. Cross-validated regularized logistic regressions for each use level by sex were used to perform feature selection and obtain prediction error statistics on independent observations. Predictors were probed for sex- and drug-specificity using post-hoc logistic regressions. Models reliably predicted use as indicated by satisfactory prediction error statistics, and contained psychosocial features common to both sexes. However, males and females exhibited distinct brain predictors that failed to predict use in the opposite sex or predict binge drinking in independent samples of same-sex participants. Collapsed across sex, genetic variation on catecholamine and opioid receptors marginally predicted use. Using machine learning techniques applied to a large multimodal dataset, we identified a risk profile containing psychosocial and sex-specific brain prognostic markers, which were likely to precede and influence cannabis initiation.

Indexed as

Sex CharacteristicsSocial BehaviorAdolescentAdolescent BehaviorBrainFemaleForecastingHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMarijuana Usemarijuananeuroimagingpredictionspecificity

Identifiers

PMID29889330
PMCPMC7444673

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.